Clinical Trial Update: Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers [NA]

View source ↗

Summary

A completed clinical trial studying insular inhibitory neuromodulation to reduce cigarette craving and alter brain function in smokers; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Snippet

Sponsor: University of Colorado, Denver | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2022-07-13